Scientific Advisory Board

Kimberly L. Blackwell, MD

Dr. Blackwell is Vice-President, Early Phase Oncology and Immuno-Oncology at Eli Lilly Corporation, and Adjunct Professor of Medicine, Duke University Medical Center.

Albert Koong, MD, PhD

Dr. Koong is the Chair of the Department of Radiation Oncology and holds the Dallas/Fort Worth Living Legend Endowed Professorship at the University of Texas MD Anderson Cancer Center.

Greg Lemke, PhD

Dr. Lemke is Fran├žoise Gilot-Salk Professor at the Salk Institute for Biological Studies, where he is a member of the Molecular Neurobiology Laboratory and Co-Director of the Immunobiology and Microbial Pathogenesis Laboratory.

Meet Our Advisors

Tom Boone

Mr. Boone has more than 34 years of accomplishments in the discovery and development of protein therapeutics. Tom worked at Amgen for 28 years and served in positions of increasing responsibility in growing Amgen Protein Sciences to an organization of over 300 researchers across five different sites while maintaining a long tradition of industry excellence.

Andrew Strong, JD

Mr. Strong is a partner in the Houston and Austin offices of Pillsbury Winthrop Shaw Pittman LLP. He has represented private and public sector clients in the life sciences, pharmaceutical, energy, transportation and real estate industries. Previously, Mr. Strong served as the General Counsel and Compliance Officer for the Texas A&M University System.